Solid Biosciences (SLDB) Free Cash Flow (2017 - 2024)
Historic Free Cash Flow for Solid Biosciences (SLDB) over the last 8 years, with Q4 2024 value amounting to -$29.8 million.
- Solid Biosciences' Free Cash Flow fell 4272.94% to -$29.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$100.7 million, marking a year-over-year decrease of 519.46%. This contributed to the annual value of -$100.7 million for FY2024, which is 519.46% down from last year.
- As of Q4 2024, Solid Biosciences' Free Cash Flow stood at -$29.8 million, which was down 4272.94% from -$23.7 million recorded in Q3 2024.
- Solid Biosciences' Free Cash Flow's 5-year high stood at $1.2 million during Q4 2020, with a 5-year trough of -$35.3 million in Q4 2022.
- Over the past 5 years, Solid Biosciences' median Free Cash Flow value was -$21.5 million (recorded in 2021), while the average stood at -$21.7 million.
- Its Free Cash Flow has fluctuated over the past 5 years, first skyrocketed by 10569.67% in 2020, then tumbled by 182686.45% in 2021.
- Solid Biosciences' Free Cash Flow (Quarter) stood at $1.2 million in 2020, then crashed by 1826.86% to -$21.5 million in 2021, then plummeted by 64.09% to -$35.3 million in 2022, then soared by 40.82% to -$20.9 million in 2023, then plummeted by 42.73% to -$29.8 million in 2024.
- Its last three reported values are -$29.8 million in Q4 2024, -$23.7 million for Q3 2024, and -$21.8 million during Q2 2024.